InvestorsHub Logo
icon url

Dogfish44

12/21/18 3:45 PM

#34137 RE: Schuller #34136

IMO you are absolutely on target with the 1.5 billion shares for RGBP! You have the talent in that RGBP calculation.

Koos education has been discussed repeatedly....and has nothing to do with anything.

RGBP is just one part of the OTC Koosglomerate shell that generates nothing but a $300K a year pay check for himself. NO PRODUCTS.... NO PHASE TRIALS.... Just PR's to generate enough Kooslaid drinking investors to keep his paycheck coming..... For over 10 years now!

RGBP is a simple transfer program.... investors $ to Koos wallet.

It should be assumed a KoosKon until he manages to actually bring a product to market or even completes a phase trial......

SEE RGBP HemaX: FDA actually green lighted phase 1 trial, and RGBP dropped the product and moved on to the current Kon.